Table 2.
Animal model/species | Experimental protocol | Result | Reference |
---|---|---|---|
Pulmonary aspergillosis C57BL/6 mice | Intraperitoneal administration of rIL-37 at doses of 1000, 100, 10 and 1 ng/mouse prior to infection | Decrease in the number of neutrophils in the BAL Suppression of NLRP inflammasome in the lungs Decreased IL-1β, IL-6, and IL-17A in the lung tissue Activation of IL-10 in the lung tissue Reduced signs of bronchial remodeling (collagenosis of lung tissue and metaplasia of bronchial epithelium) Suppression of lung infiltration with Th2/Th17 cells. | [48] |
OVA-induced BA. C57BL/6 mice | Intranasal administration of rIL-37 at a dose of 1 μg/mouse 1 day prior to aerosol administration of OVA | Decreased eosinophil count in BAL and lung tissue Suppression of bronchial epithelium hyperplasia, mucus production and bronchial hyperreactivity Suppression of pro-inflammatory cytokines in BAL: IL-6, IL-12, IL-4, IL-5, and IL-13 | [50] |
HDM-induced AR BALB/c mice | Intranasal administration of rIL-37 at a dose of 1 μg/mouse in combination with nasal provocation with HDM | Threefold reduction in nasal hyperreactivity Decreased levels of allergen-specific antibodies of the IgE class Suppression of eosinophilic infiltration to the mucosa of the nasal cavity Suppression of the pro-inflammatory cytokines IL-4, IL-5, IL-13 and IL-17 in the nasal mucosa and activation of regulatory IL-10 | [70] |
OVA-induced BA BALB/c mice | Intranasal administration of rIL-37 at a dose of 1 μg/mouse in combination with allergen provocation | Decreased bronchial hyperreactivity and lung infiltration by pro-inflammatory cells (lymphocytes, neutrophils, and eosinophils) Inhibition of IL-4, IL-6, and IL-13 in lung tissue Decrease in proliferation and migration of respiratory smooth muscle cells and epithelial-mesenchymal transition | [68] |
HDM-induced BA BALB/c mice | Intranasal administration of rIL-37 at a dose of 0.2 μg/mouse combined with sensitization or nasal provocation with HDM | Decrease in the number of eosinophils in BAL and lung tissue, decreased bronchial hyperreactivity IL-37 suppressed IL-4/13-induced production of CCL11 fibroblasts and respiratory smooth muscle cells | [69] |
Note:
rIL-37 – recombinant interleukin-37;
BAL – bronchoalveolar lavage;
BA – bronchial asthma;
OVA – ovalbumin allergen;
HDM – house dust mite allergen.